1. Home
  2. KRKR vs SNGX Comparison

KRKR vs SNGX Comparison

Compare KRKR & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

HOLD

Current Price

$2.80

Market Cap

5.5M

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.37

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRKR
SNGX
Founded
2010
1987
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.6M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
KRKR
SNGX
Price
$2.80
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
9.3K
412.3K
Earning Date
03-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.28
52 Week High
$21.36
$6.23

Technical Indicators

Market Signals
Indicator
KRKR
SNGX
Relative Strength Index (RSI) 45.59 41.74
Support Level $2.51 $0.37
Resistance Level $2.89 $0.41
Average True Range (ATR) 0.22 0.02
MACD 0.04 0.01
Stochastic Oscillator 28.67 55.38

Price Performance

Historical Comparison
KRKR
SNGX

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in the PRC.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: